CDC Group Plc, the UK’s development finance institution that will soon be renamed British International Investment, has appointed four new managing directors.
The firm named Abhinav Sinha managing director and head of technology and telecoms, Amal-Lee Amin as MD and head of climate, and Chris Chijiutomi as MD and head of infrastructure equity for Africa and Pakistan.
It has also appointed Yasemin Saltuk Lamy as MD and head of asset allocation and capital solutions.
Sinha, Amin and Chijiutomi were previously directors in their respective departments while Lamy was deputy CIO.
CDC said it made the appointments as it enters its new five-year strategy period in which it will prioritise investment in clean infrastructure and climate finance projects.
IIM Calcutta graduate Sinha joined CDC in 2018. He has been responsible for leading some of the most significant investments at CDC including in Africa’s Liquid Telecom, the mobile partnership with Vodacom in Ethiopia and setting up Kelix Bio, the cross-border pharmaceutical manufacturing platform.
Sinha started his career at Boston Consulting Group and then had a short stint at CLSA. He then joined Eight Roads, a venture growth investment firm where he spent nine years before moving to CDC.
Amin has led cross-firm initiatives to align investment strategies with the goals of the Paris Agreement.
Chijiutomi has led CDC’s infrastructure equity team since 2018 and sits on the boards of Globeleq and Gridworks, the firm’s key investments in Africa’s power sector. He also provided overall leadership and supervision of CDC’s joint venture with DP World in the creation of a platform to invest in ports and logistics assets in Africa.
Under Lamy’s leadership since 2018, CDC’s Catalyst portfolio has doubled in size, reaching $1 billion of commitments and helping more than 40 million people, the development financier said.